Here are the 424B prospectus supplements from Arcadia Biosciences, Inc. (RKDA) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow RKDA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full RKDA filings page.
Arcadia Biosciences, Inc. is registering 11,922,333 shares of Common Stock for resale by the selling stockholders, representing shares issuable upon exercise of pre-funded warrants, preferred investment options and placement agent preferred investment options. The registration covers resale on a resale basis and the company will not receive proceeds from sales by the selling stockholders.
The prospectus states the company would receive proceeds only if the Options are exercised for cash and discloses potential gross cash proceeds of approximately $7.4 million if all Options were exercised for cash. Shares outstanding were 2,181,715 before this registration and would be 14,104,048 assuming full exercise of the Options as described.
Arcadia Biosciences, Inc. is registering for resale up to 1,673,792 shares of common stock, issuable upon exercise of preferred investment options held by existing investors and placement agents. This includes up to 1,617,190 shares from new Investment Options and 56,602 shares from Placement Agent Options.
The company will not receive proceeds from stockholder resales, but could receive up to approximately $3.94 million if all options are exercised for cash, which it plans to use for working capital and general corporate purposes. Common stock outstanding was 1,729,884 shares as of January 23, 2026, and would be 3,403,676 shares assuming full cash exercise of the Options. Arcadia now focuses on its Zola coconut water brand after selling several legacy crop-related assets, and discloses substantial doubt about its ability to continue as a going concern without additional financing. A previously planned all-stock business combination with Roosevelt Resources, LP has been terminated.